William E. Rote

Companies

• Travere Therapeutics, Inc.Senior Vice President, R&D Feb 15, 2017 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX98,197 shares²$5.2M at $53.15Sep 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 16, 2026Sold 47,746 shares at $63.61 of Travere Therapeutics, Inc.²
• Sep 16, 2026Sold 65,104 shares at $63.12 of Travere Therapeutics, Inc.²
• Sep 16, 2026Exercised options 57,500 shares at $26.88 of Travere Therapeutics, Inc.²
• Sep 16, 2026Exercised options 55,000 shares at $15.46 of Travere Therapeutics, Inc.²
• Sep 16, 2026Exercised options 350 shares at $17.96 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 270 shares at $65.31 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 3,000 shares at $63.65 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 29,021 shares at $62.66 of Travere Therapeutics, Inc.²
• Sep 15, 2026Sold 63,907 shares at $61.99 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 39,650 shares at $17.96 of Travere Therapeutics, Inc.²
• Sep 15, 2026Exercised options 39,000 shares at $25.25 of Travere Therapeutics, Inc.²
• May 6, 2026Sold 2,763 shares at $43.95 of Travere Therapeutics, Inc.³
• May 4, 2026Exercised options 4,250 shares of Travere Therapeutics, Inc.³
• Apr 22, 2026Sold 9,100 shares at $39.09 of Travere Therapeutics, Inc.⁴
• Apr 13, 2026Granted 14,000 shares of Travere Therapeutics, Inc.⁵
• Feb 3, 2026Sold 12,446 shares at $32.87 of Travere Therapeutics, Inc.⁶
• Jan 31, 2026Granted 20,090 shares of Travere Therapeutics, Inc.⁶
• Dec 24, 2025Sold 60,000 shares at $40.10 of Travere Therapeutics, Inc.⁷
• Dec 24, 2025Exercised options 60,000 shares at $20.61 of Travere Therapeutics, Inc.⁷
• May 5, 2025Sold 3,198 shares at $21.05 of Travere Therapeutics, Inc.⁸
• May 2, 2025Exercised options 4,920 shares of Travere Therapeutics, Inc.⁸
• Feb 12, 2025Sold 5,200 shares at $23.53 of Travere Therapeutics, Inc.⁹
• Feb 10, 2025Exercised options 8,000 shares of Travere Therapeutics, Inc.⁹
• Feb 3, 2025Sold 8,951 shares at $19.78 of Travere Therapeutics, Inc.¹⁰
• Jan 31, 2025Granted 21,500 shares of Travere Therapeutics, Inc.¹⁰